Research & Development

Lundbeck’s goal is to be a world leader in providing therapies for psychiatric and neurological disorders.

At Lundbeck, we devote our R&D efforts to create innovative therapies for the treatment of central nervous system (CNS) disorders. Our R&D projects focus on:

  • Depression and anxiety
  • Psychosis
  • Bipolar disorder
  • Alzheimer’s disease
  • Parkinson’s disease
  • Huntington’s disease
  • Epilepsy
  • Stroke
  • Alcohol dependence
  • Lennox-Gastaut syndrome

Research is our foundation

We acknowledge that the continued growth of our company depends on the achievements of our R&D employees. Thus, innovative research and development is the basis for our future.
Our tasks in Lundbeck R&D are to discover and develop novel therapies and to function as a center of expertise for the biology of CNS diseases and treatment options.

Research is a way of life

Lundbeck R&D is known worldwide for its pioneering work within the field of psychiatry. We are building on this strength in neurology. As a medium-sized pharmaceutical company, we share common values in the way we work worldwide and keep a clear focus in our R&D strategy.

As an international organization, we have research teams in both Denmark and the United States.

Our corporate development team is headquartered in Copenhagen, Denmark with offices throughout the world.

Research at Lundbeck is based on the efforts of our multi-disciplinary, empowered project teams, our in-house expertise in the CNS disease area, and our state-of-the-art technologies. We work in new, well-equipped laboratories. Each project team integrates our advanced knowledge in R&D disciplines with expertise in clinical practices and therapeutic needs.

Our strong competencies make Lundbeck an attractive partner, and we have extensive international collaborations with leading academic and institutional research centers and industry partners.

Respect for the individual

At Lundbeck R&D, we work together towards a common goal as a team of unique individuals. We seek to constantly develop and improve our scientific and personal skills and qualifications. This allows us to promote career opportunities for the individual, as well as maintain and develop our competencies as an organization. Publication of our scientific results is a natural part of our participation as active members in the international scientific community.

After all, our growth relies on our talented employees and their innovative efforts.

Pipeline

By clicking below you will be transferred from the Lundbeck Inc. website to the
H. Lundbeck A/S website. Some of the products and compounds displayed on the pipeline page have not been approved by the FDA as being safe or effective for the use under study. The information provided  is for general information only and is not intended to provide medical advice or guidance and should not be used for that purpose. In the United States, a drug is not considered safe or effective for its intended use unless approved by the FDA.

 

Click here

Research

Our full service research facility in Paramus, NJ, is part of a global research organization.

Focused on synaptic transmission, neurodegeneration and neuroinflammation, Lundbeck's research focus drives the company's innovative approach to identifying new medicines in psychiatry and neurology.

Contact Lundbeck Research in the U.S.:
215 College Road
Paramus, New Jersey 07652-1431
(201) 261-1331

Contact Lundbeck Research USA

You have chosen to visit another Lundbeck website or a third-party website, which is provided as a service to you. Lundbeck Inc. does not control content on third-party websites and cannot make representations concerning the accuracy of information on every website you visit. Lundbeck Inc. is not responsible for the privacy policy of any third-party website. We encourage you to read the privacy policy of every website you visit. Click OK to continue or Cancel to return to Lundbeck Inc.